Clinical Trial Update: Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia [Phase 2]

View source ↗

Summary

Phase 2 trial update on safety and efficacy of EPI-743 in Friedreich's Ataxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• EPI-743

Snippet

Sponsor: PTC Therapeutics | Conditions: Friedreich's Ataxia | Phase 2 | Status: COMPLETED